Delisting risk
NuCana (ADR) (NCNA)
Develops ProTide oncology candidates that redesign nucleoside agents for cancer cells.
$1.38
Pre-market−0.03 (−2.09%)
At close$1.41(+1.81%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
estimated · in 70 days
EPS estimate
−$2.70
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25Jun '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$64.00−$126.00−$0.16−$0.10−$1.47−$1.25−$0.99Pending
Estimate−$486.00−$2.58−$2.75−$2.69−$2.69−$2.64−$2.65−$2.70
Surprise+86.8%−4,778.0%+94.2%+96.3%+45.4%+52.7%+62.7%—
RevenueReportedEstimate
Mar '25Jun '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$2.70 | — | — |
| Aug 2026 | −$2.65 | −$0.99 | +62.7% |
| May 2026 | −$2.64 | −$1.25 | +52.7% |
| Mar 2026 | −$2.69 | −$1.47 | +45.4% |
| Nov 2025 | −$2.69 | −$0.10 | +96.3% |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| Jun 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Apr 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Jun 2022 | |||
| Apr 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Oct 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$2.70 | — | — | — | — | — | — |
| Aug 13, 2026 | −$2.65 | −$0.99 | +62.7% | — | — | — | +7.4% |
| May 14, 2026 | −$2.64 | −$1.25 | +52.7% | — | — | — | +10.1% |
| Mar 19, 2026 | −$2.69 | −$1.47 | +45.4% | — | — | — | −3.5% |
| Nov 13, 2025 | −$2.69 | −$0.10 | +96.3% | — | — | — | −2.3% |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | |||||||
| Aug 20, 2025 | |||||||
| Jun 2, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 25, 2024 | |||||||
| Aug 15, 2024 | |||||||
| May 16, 2024 | |||||||
| Mar 20, 2024 | |||||||
| Nov 16, 2023 | |||||||
| Aug 16, 2023 | |||||||
| May 17, 2023 | |||||||
| Apr 4, 2023 | |||||||
| Nov 16, 2022 | |||||||
| Aug 17, 2022 | |||||||
| Jun 2, 2022 | |||||||
| Apr 27, 2022 | |||||||
| Nov 18, 2021 | |||||||
| Aug 19, 2021 | |||||||
| May 19, 2021 | |||||||
| Mar 4, 2021 | |||||||
| Nov 19, 2020 | |||||||
| Aug 19, 2020 | |||||||
| May 19, 2020 | |||||||
| Mar 10, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 21, 2019 | |||||||
| May 14, 2019 | |||||||
| Mar 7, 2019 | |||||||
| Nov 27, 2018 | |||||||
| Oct 1, 2018 | |||||||
| May 23, 2018 | |||||||
| Mar 21, 2018 | |||||||
| Nov 15, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||